-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$15.50101.04% Upside
Precision BioSciences, Inc. Frequently Asked Questions
-
What analysts cover Precision BioSciences, Inc.?
Precision BioSciences, Inc. has been rated by research analysts at BTIG, Goldman Sachs in the past 90 days.